16,688 Shares in Option Care Health, Inc. $OPCH Purchased by Dynamic Technology Lab Private Ltd

Key Points

• Dynamic Technology Lab Private Ltd has made a new investment of approximately $583,000 in Option Care Health, acquiring 16,688 shares of the company.
• Option Care Health's stock is currently down 1.9% and has a market capitalization of $4.66 billion, with a price-to-earnings ratio of 22.96.
• A number of analysts have raised their price targets for Option Care Health to $38.00, with eight analysts giving the stock a Buy rating and one a Hold rating.

Dynamic Technology Lab Private Ltd bought a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 16,688 shares of the company's stock, valued at approximately $583,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. grew its stake in Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares during the period. Brooklyn Investment Group grew its stake in Option Care Health by 186.6% in the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after acquiring an additional 780 shares during the period. Public Employees Retirement System of Ohio boosted its holdings in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares during the last quarter. Bessemer Group Inc. boosted its holdings in shares of Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares during the last quarter. Finally, Wealthquest Corp acquired a new position in shares of Option Care Health in the 1st quarter valued at $66,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on OPCH. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Stock Down 1.2%

OPCH stock traded down $0.33 during trading on Tuesday, reaching $27.56. The stock had a trading volume of 2,011,690 shares, compared to its average volume of 1,799,825. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $4.47 billion, a P/E ratio of 22.05, a PEG ratio of 1.70 and a beta of 0.82. The firm has a fifty day moving average price of $28.96 and a 200 day moving average price of $31.35.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the previous year, the business posted $0.30 EPS. The firm's revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the business's stock in a transaction dated Wednesday, August 20th. The shares were acquired at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the purchase, the director owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Norman L. Wright bought 3,411 shares of the business's stock in a transaction dated Tuesday, September 9th. The stock was bought at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares in the company, valued at approximately $454,334.31. This represents a 28.21% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 59,411 shares of company stock valued at $1,627,576. Insiders own 0.64% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.